Home
>
National Drug Code (NDC)
>
butalbital, aspirin, caffeine and codeine phosphate
butalbital, aspirin, caffeine and codeine phosphate - 63629-2952-4 - (butalbital, aspirin, caffeine and codeine phosphate)
Drug Information of butalbital, aspirin, caffeine and codeine phosphate
| Product NDC: | 63629-2952 |
| Proprietary Name: | butalbital, aspirin, caffeine and codeine phosphate |
| Non Proprietary Name: | butalbital, aspirin, caffeine and codeine phosphate |
| Active Ingredient(s): | 325; 50; 40; 30 mg/1; mg/1; mg/1; mg/1 & nbsp; butalbital, aspirin, caffeine and codeine phosphate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of butalbital, aspirin, caffeine and codeine phosphate
| Product NDC: | 63629-2952 |
| Labeler Name: | bryant ranch prepack |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075231 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100330 |
Package Information of butalbital, aspirin, caffeine and codeine phosphate
| Package NDC: | 63629-2952-4 |
| Package Description: | 60 CAPSULE in 1 BOTTLE (63629-2952-4) |
NDC Information of butalbital, aspirin, caffeine and codeine phosphate
| NDC Code | 63629-2952-4 |
| Proprietary Name | butalbital, aspirin, caffeine and codeine phosphate |
| Package Description | 60 CAPSULE in 1 BOTTLE (63629-2952-4) |
| Product NDC | 63629-2952 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | butalbital, aspirin, caffeine and codeine phosphate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20100330 |
| Marketing Category Name | ANDA |
| Labeler Name | bryant ranch prepack |
| Substance Name | ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE |
| Strength Number | 325; 50; 40; 30 |
| Strength Unit | mg/1; mg/1; mg/1; mg/1 |
| Pharmaceutical Classes | Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
